The NHS Cancer Programme has awarded £14.4 million through SBRI Healthcare to support 16 pioneering projects aimed at improving early cancer detection and diagnosis across the UK.
UC Berkeley scientists unveil a powerful new at-home test using nanotech and AI to detect diseases like COVID-19 and cancer with unprecedented sensitivity.
An 'AI scientist', working in collaboration with human scientists, has discovered that combinations of cheap and safe drugs could be effective at treating breast cancer.
World Cancer Research Fund International (WCRFI) is a not-for-profit organisation that leads a network of cancer prevention charities, including the American Institute for Cancer Research, World Cancer Research Fund in the UK, Wereld Kanker Onderzoek Fonds in the Netherlands and World Cancer Research Fund Hong Kong. They are dedicated to funding research on cancer, specifically how diet, weight, and physical activity affect cancer risk and survival.
The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis, as the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to its new artificial intelligence-powered companion diagnostic device, the VENTANA® TROP2 (EPR20043) RxDx.
Researchers from the University of Cambridge and the NIHR Cambridge Biomedical Research Centre have created an algorithm that finds vulnerable cancer tumours.
In a world first, the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved trofolastat to detect cancerous lesions in men with prostate cancer.
Researchers have revealed a new finding that could improve cancer care immunotherapy treatments, particularly for chronic lymphocytic leukaemia (CLL) and other cancers.
A recent study led by experts from the University of Manchester suggests that introducing a UK-wide sampling program alongside the existing cervical smear test could help remove the barriers that prevent people from attending cervical screening.
